Causes and prevalence of visual impairment among adults in the United States. - Wikidata - awgldk - TriplyDB

Causes and prevalence of visual impairment among adults in the United States.

Causes and prevalence of visual impairment among adults in the United States.

http://www.wikidata.org/entity/Q46890945

about

CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD Mapping glaucoma patients' 30-2 and 10-2 visual fields reveals clusters of test points damaged in the 10-2 grid that are not sampled in the sparse 30-2 grid Blood pressure control for diabetic retinopathy Telerehabilitation for people with low vision Blue-light filtering intraocular lenses (IOLs) for protecting macular health Anti-vascular endothelial growth factor for neovascular age-related macular degeneration Topical medication instillation techniques for glaucoma Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty Telerehabilitation for people with low vision Reading aids for adults with low vision Orientation and mobility training for adults with low vision Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration Reading aids for adults with low vision Blood pressure control for diabetic retinopathy Nutritional supplements for age-related macular degeneration Informing food choices and health outcomes by use of the dietary glycemic index Dysregulation of human bestrophin-1 by ceramide-induced dephosphorylation Age-related eye diseases: an emerging challenge for public health professionals Comparison of Outcomes of Resident-performed Ahmed Valve Implantation vs Trabeculectomy Epidemiological and Clinical Baseline Characteristics as Predictive Biomarkers of Response to Anti-VEGF Treatment in Patients with Neovascular AMD Optogenetics for neurodegenerative diseases.The Treatment Paradigm for the Implantable Miniature Telescope Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives Individualized Treatment of Neovascular Age-Related Macular Degeneration: What are Patients Gaining? Or Losing?Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition The prevalence of age-related eye diseases and visual impairment in aging: current estimates At the interface of sensory and motor dysfunctions and Alzheimer's disease.The unfolded protein response and diabetic retinopathy Health state utility values for diabetic retinopathy: protocol for a systematic review and meta-analysis Shanghai eye treatment outbreak: bevacizumab therapy for AMD in China Advances in the genomics of common eye diseases Projected prevalences of age-related eye diseases The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey Bioptic Telescope Use and Driving Patterns of Drivers with Age-Related Macular Degeneration.Projection-resolved optical coherence tomographic angiography Early detection of age related macular degeneration: current status Ranibizumab for age-related macular degeneration: a meta-analysis of dose effects and comparison with no anti-VEGF treatment and bevacizumab

P2860

Q21090046-FCF52072-3971-4B15-9098-C1C562D79212 Q21132027-C8C966AB-FA12-41BF-A841-07E94DCC6F5E Q24186434-73AEFD90-A625-457A-9E09-922650FCB72A Q24187720-2F7E48A1-3EEF-42FE-9D84-FBE03FB5501C Q24188090-1051D93F-78A6-46F4-9AE4-B61519F0ACE2 Q24194251-96ACB13A-EF0B-42B4-8985-6E6F1FF47B94 Q24197532-5222ADA8-7C2C-4083-9927-20A5548D3038 Q24198883-3E52A1B7-8494-4E3A-BE24-DEBD6BC00C05 Q24198921-1E7A15F7-AF9F-4742-981E-73690F285929 Q24202948-DAD89485-BB6B-4541-89BC-E4A4FB3AAA82 Q24235380-3BB6DCA8-2153-42C8-8CB8-D1BD5D18567D Q24243234-D220EB1E-073A-40E1-9C52-42DC2E198F54 Q24243887-FAA5B0FA-70F8-4B8C-98EB-B106507128A7 Q24245872-75307706-6F28-4CF4-BE22-4DB79D198DA9 Q24603642-5B3F9CA7-D886-4A1B-AB9E-85D4D445686E Q24626304-E8625C23-A6DE-44F9-B7F1-A8EF74115139 Q24649131-39048184-BFBF-4A94-95CB-F6E6167D41BE Q25257145-1A41626D-D00D-4CB8-9C2F-88DAD67D2784 Q26741004-48DEEC43-6440-4C2D-8359-6E00AB491903 Q26748731-15138411-3AC9-43C3-A112-7D787EE6B67F Q26749238-BF96A10A-ECFB-46CA-BF5B-496000E3682D Q26749297-B8F40DFF-9500-43C4-8CC7-6890D430BCE3 Q26773085-46351658-7057-45B6-A04C-991CF8122CF5 Q26778521-FD852A9C-AF1F-4D05-A6C6-BBF229EC55A1 Q26799492-A4879198-6070-49AE-92D5-FF585075C3BB Q26823002-F4178A30-5BED-42EA-87FB-1680801BE115 Q26824335-A63C072F-34F8-4243-9EC6-F59AAD713D5F Q26851574-34319548-6BAF-44B5-A18E-4BBC8E9305E4 Q26859008-D7C26AC8-6202-463C-9A9C-7F7A8B03F355 Q27000410-D0DCF83E-13F8-49B6-A668-CF6C5B1A7713 Q27000603-A5D31125-D8DF-472D-8A92-0703F92C8A66 Q27004266-9BFB7EF8-4C83-45F4-9CBC-B27E54394DA5 Q27008066-1568EAA2-6B0C-4C77-A4D3-75ADB039B70B Q27008236-74FE9C72-CA84-4F08-A206-3E16EF2A4574 Q27027722-526F8833-4458-4709-B6CC-2CFB129D90FF Q27304716-21EA3180-3D24-42F0-91FC-7475761F5329 Q27334406-52A15251-E21A-4F73-A338-93CEB6089D21 Q27335908-1B1E4F91-25C2-47D0-883B-E496616EE405 Q28076117-EE9D1633-8E1B-4855-BF22-5BFA14E3DE65 Q28236004-41A37C2E-569A-4D0B-98D2-0CFB75CAC0D3

P2860

Causes and prevalence of visual impairment among adults in the United States.

http://www.wikidata.org/entity/Q46890945

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Causes and prevalence of visual impairment among adults in the United States.

@en

Causes and prevalence of visual impairment among adults in the United States.

@nl

type

label

Causes and prevalence of visual impairment among adults in the United States.

@en

Causes and prevalence of visual impairment among adults in the United States.

@nl

prefLabel

Causes and prevalence of visual impairment among adults in the United States.

@en

Causes and prevalence of visual impairment among adults in the United States.

@nl

P1433

Q46890945-ED8B7049-0FB5-4480-978B-EA01BCCAD2A1

P1476

Q46890945-756A4B13-5F9E-4053-9B59-013A4AEF30FE

P2093

Q46890945-0941FFC3-891A-40B5-9181-9B5332DB1E80

Q46890945-1EDF8BDB-D5ED-4D55-A235-0DB5D07BAD65

Q46890945-324E4622-90AA-42AC-893A-00D07B0DD8D1

Q46890945-41206765-4ED9-4F58-A465-C71F9B0D916C

Q46890945-55CE2C52-2488-4DE2-A9A5-29774D6B07D8

Q46890945-5B0FA4DA-48CF-4248-AC1A-8E296226A643

Q46890945-9455AC50-3419-4566-9727-88EC995743A4

Q46890945-D4BD46F6-094B-43B4-A02F-16BB88313888

Q46890945-F33F9FCC-1247-4143-AF6C-7C451D52FDD1

P304

Q46890945-1E9F6624-B68F-44B6-9830-2C2B723C1EB7

P31

Q46890945-DE0D15B5-9923-446D-8CD2-8FC5BA72A23F

P356

Q46890945-50E53BEC-5012-4154-8940-B2B18BD2EBEE

P407

Q46890945-15EB954F-B604-49AE-9E51-DEB44712B92D

P433

Q46890945-8FF59749-0511-4810-8566-1EAB70FB9E54

P478

Q46890945-3A870A45-6D64-4156-98D7-42750AD08B88

P50

Q46890945-A3712731-A1A0-46FA-91FB-D2486D903E7A

P577

Q46890945-E5BA9606-B1F1-48E6-BF70-F5C05D602A46

P698

Q46890945-2CCA8057-8250-4979-82C1-762AB90CFBB9

P356

ARCHOPHT.122.4.477

P1433

JAMA Ophthalmology

P1476

Causes and prevalence of visual impairment among adults in the United States.

@en

P2093

Benita O'Colmain

http://www.w3.org/2001/XMLSchema#string

Caroline C W Klaver

http://www.w3.org/2001/XMLSchema#string

David S Friedman

http://www.w3.org/2001/XMLSchema#string

Eye Diseases Prevalence Research Group

http://www.w3.org/2001/XMLSchema#string

Hugh R Taylor

http://www.w3.org/2001/XMLSchema#string

John Kempen

http://www.w3.org/2001/XMLSchema#string

Nathan Congdon

http://www.w3.org/2001/XMLSchema#string

Paul Mitchell

http://www.w3.org/2001/XMLSchema#string

Ronald Klein

http://www.w3.org/2001/XMLSchema#string

P304

477-485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHOPHT.122.4.477

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15078664

http://www.w3.org/2001/XMLSchema#string